Position in BMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$276,039,838
-$99,878,984 QoQ
Shares Held
4,790,695
-22.7% QoQ
Ownership
0.235%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#55
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $21,591,255,986 across 16 Drug Manufacturers - General names. BMY ranks #11 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,590,218 | $5,505,645,627 | |
| 2 | ABBV |
AbbVie Inc.
|
19,925,232 | $5,013,985,374 | |
| 3 | AZN |
Astrazeneca PLC
|
16,511,727 | $3,130,953,667 | |
| 4 | JNJ |
Johnson & Johnson
|
10,086,602 | $2,561,694,303 | |
| 5 | MRK |
Merck & Co., Inc.
|
19,548,585 | $2,511,993,169 | |
| 6 | NVO |
Novo Nordisk A S
|
13,041,109 | $625,190,761 | |
| 7 | NVS |
Novartis AG
|
3,251,281 | $509,540,755 | |
| 8 | AMGN |
Amgen Inc
|
1,365,550 | $494,492,960 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $276,039,838 | 4,790,695 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $375,918,822 | 6,198,167 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $461,249,404 | 8,551,157 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $392,467,861 | 8,702,170 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $390,539,975 | 8,436,811 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $211,936,706 | 3,474,942 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $196,403,917 | 3,472,488 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $184,393,750 | 3,563,853 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $239,915,649 | 5,776,924 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $627,552,051 | 11,572,046 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $480,117,878 | 9,357,199 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $397,403,648 | 6,847,065 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $340,369,650 | 5,322,434 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $260,085,910 | 3,752,502 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $198,832,023 | 2,763,475 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $619,969,631 | 8,720,912 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $931,681,982 | 12,099,766 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,162,834,703 | 15,922,699 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $846,969,879 | 13,584,120 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $826,035,266 | 13,960,373 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,057,643,326 | 15,828,245 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,229,041,729 | 19,468,426 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $886,777,031 | 14,295,938 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $556,672,397 | 9,233,246 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $438,713,794 | 7,461,119 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $420,478,367 | 7,543,566 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||